Pluri (PLUR) Other Working Capital Changes (2010 - 2025)
Pluri (PLUR) reported Other Working Capital Changes of -$61000.0 for Q4 2025, up 78.37% year-over-year from -$34198.8 in Q4 2024, and down 41.86% quarter-over-quarter from -$43000.0 in Q3 2025.
Pluri (PLUR) Other Working Capital Changes (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Other Working Capital Changes data on file, last reported at -$61000.0 in Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at -$61000.0, up 78.37% year-over-year; the trailing twelve-month figure through Dec 2025 was $89000.0 (up 116.33% YoY), and the FY2025 annual result was -$42000.0, up 85.26% from the prior year.
- Other Working Capital Changes fell to -$61000.0 in Q4 2025 per PLUR's latest filing, from -$43000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.2 million in Q4 2022 and troughed at -$674000.0 in Q3 2022.
- A 5-year average of -$41850.0 and a median of -$25500.0 in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes plunged 6862.5% in 2023, then jumped 590.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $227000.0 in 2021, then surged by 417.18% to $1.2 million in 2022, then slumped by 131.18% to -$366000.0 in 2023, then climbed by 22.95% to -$282000.0 in 2024, then soared by 78.37% to -$61000.0 in 2025.
- Business Quant data shows PLUR's Other Working Capital Changes at -$61000.0 in Q4 2025, -$43000.0 in Q3 2025, and $237000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -61,000.00 |
| Dec 31, 2025 | -61,000.00 |
| Sep 30, 2025 | -43,000.00 |
| Sep 30, 2025 | -43,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -282,000.00 |
| Dec 31, 2024 | -282,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Sep 30, 2024 | 47,000.00 |
| Jun 30, 2024 | -379,000.00 |
| Jun 30, 2024 | -379,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Mar 31, 2024 | 69,000.00 |
| Dec 31, 2023 | -366,000.00 |
| Dec 31, 2023 | -366,000.00 |
| Sep 30, 2023 | 391,000.00 |
| Sep 30, 2023 | 391,000.00 |